Dianeysis Avendano, PharmD BCPS BCSCP: No financial relationships to disclose
Cheryl Garvin, RPh, FACP: The Compounding Center: Shareholder (Ongoing)
Jim Gaither, PharmD BCSCP: No financial relationships to disclose
Compounding facilities were expected to be compliant with the most recent updates to USP 795 and 797 by November 2023, but this was no easy task considering the extent of the revisions. Attend this session to hear best practices from a panel of experts who have implemented the updates in their facilities.
Identify relevant updates to USP 795 and 797 that impacted standard operating procedures.
Discuss barriers that occurred when implementing updates to USP 795 and 797 in practice.
Recall resources available for pharmacists and pharmacy administrators related to 503B compounding pharmacies.